Mutation Frequency Coverage Chromosome Position Reference Mutation Platform
0.5063 399 10 43613843 G T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.4906 638 10 43613843 G T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.2 n/a 10 43613843 G T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.535 1641 10 89717672 C T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.5781 365 10 89717672 C T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.16 n/a 10 89717672 C T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9976 1698 13 28610183 A G IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9975 405 13 28610183 A G IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
1 n/a 13 28610183 A G IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9976 1695 17 7579472 G C IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9597 248 17 7579472 G C IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
1 47 17 7579472 G C IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9908 1305 4 1807894 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9933 445 4 1807894 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
1 24 4 1807894 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.3494 5045 4 55141026 C T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.3003 323 4 55141026 C T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.4554 101 4 55141026 C T IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9982 5046 4 55141055 A G IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
1 327 4 55141055 A G IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9915 118 4 55141055 A G IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9873 10988 5 112175770 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.997 331 5 112175770 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.9844 257 5 112175770 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.6609 4064 7 55249063 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.6438 306 7 55249063 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
0.5737 190 7 55249063 G A IlluminaMiSeq Ion Torrent PGM MiSeq (Biochain)
Table 3: Sequences shared by the two cancer panels showed excellent concordance between platforms and labs for variants with high variant frequency.